Denmark vs Nicaragua: Pneumococcal conjugate second or third-dose vaccines (PCVc)
Denmark
96.0%
in 2025
Nicaragua
96.0%
in 2025
Denmark rank
26th
Nicaragua rank
26th
Pneumococcal conjugate second or third-dose vaccines (PCVc) over time
- Denmark
- Nicaragua
How they compare
Denmark currently reports 96.0% against 96.0% in Nicaragua, a difference of 0.0%.
The two have swapped places 4 times across 18 shared years of data; in 2008 it was Nicaragua ahead.
Denmark ranks 26th and Nicaragua ranks 26th of 192 countries.
Across the 3 decades both report, Denmark averaged higher in 2 and Nicaragua in 1.
Head to head by decade
| Decade | Denmark | Nicaragua | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 43.0% | 0.0% | 43.0% | Denmark |
| 2010s | 93.3% | 85.3% | 8.0% | Denmark |
| 2020s | 96.2% | 97.8% | 1.7% | Nicaragua |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), Denmark or Nicaragua?
- Denmark, at 96.0% against 96.0% in Nicaragua as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between Denmark and Nicaragua?
- 0.0%, with Denmark ahead.
- How many years of comparable data are there for Denmark and Nicaragua?
- 18 years are reported by both, from 2008 to 2025.
- How do Denmark and Nicaragua rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Denmark ranks 26th and Nicaragua ranks 26th of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.